Nina Cash started modeling as an “encore career” after retirement — and was named winner of the 2023 Sports Illustrated Swim Search at the age of 57. For her photo shoot, she headed to glamorous, ...

Daily Brief Keep abreast of Evanston’s latest news and features with our free newsletter. Raising Evanston The RoundTable’s free weekly newsletter featuring everything E-town for families. Sign up ...

Phoenix (AP) — An Arizona man was convicted Thursday on eight murder charges for a string of fatal shootings that targeted random victims and his own mother and stepfather over a three-week span. The ...

Kala Bio, Inc. (NASDAQ:KALA), a biotech company with a market capitalization of $10.74 million and showing significant stock volatility, announced it received a written notice of default from Oxford ...

In this video, we compare a can of Silly String with a 60,000 psi waterjet cutter to explore their differences in performance. #SillyString #WaterjetCutter #ScienceExperiment Pub owner’s huge call ...

Tom Bowen is a senior editor who loves adventure games and RPGs. He's been playing video games for several decades now and writing about them professionally since 2020. Although he dabbles in news and ...

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. Always be cautious before investing in a penny stock.

Sept 29 (Reuters) - Kala Bio (KALA.O), opens new tab will stop developing its experimental treatment for a type of eye condition after it failed to meet the main goal in a mid-stage study, sending the ...

President Donald Trump spent his Sunday night bombarding his Truth Social followers with random conspiracy theory videos. In a flurry of 12 reposts in under 15 minutes, the president promoted several ...

Investing.com - Kala Bio (NASDAQ:KALA), a clinical-stage biopharmaceutical company with a market capitalization of $133.75 million, announced Monday that its KPI-012 treatment failed to meet both ...

ARLINGTON, Mass., Sept. 29, 2025 (GLOBE NEWSWIRE) -- KALA BIO, Inc. (NASDAQ:KALA), a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of innovative ...